Recent mechanistic insights have revealed that breast cancer stem cells (BCSCs) can secrete macrophage migration inhibitory factor (MIF), which activates the WNT/β-catenin signaling axis, subsequently upregulating MYC and its downstream effector, the glycolytic enzyme ALDOC. The gene discussed is MIF; the disease is breast carcinoma.